Deprescribing to optimise drug therapy
Debi Bhattacharya is Professor of Behavioural Medicine at the University of Leicester, UK. As a former primary care pharmacist, she has experience of both practice and research into […]
Debi Bhattacharya is Professor of Behavioural Medicine at the University of Leicester, UK. As a former primary care pharmacist, she has experience of both practice and research into […]
The time has come and gone for universal masking in healthcare settings, according to healthcare epidemiologists and infectious diseases experts from healthcare systems throughout Boston and beyond. In […]
The CHARMER study of a proactive deprescribing intervention is different from previous studies and addresses five critical factors identified by prescribers and patients as being key to success, […]
A qualitative case series research study sponsored by the American College of Lifestyle Medicine and published in Clinical Diabetes provides the first published examples of protocols to help guide clinical decision making […]
There is no ‘one-size-fits-all’ deprescribing intervention and a good understanding of the barriers and enablers to effective deprescribing is needed, according to Debi Bhattacharya, Professor of Behavioural Medicine […]
Researchers at UNSW Sydney and Neuroscience Research Australia (NeuRA) have developed and evaluated a tool for assessing dementia risk, with promising initial results. Currently, over 55 million people are living with dementia […]
Debi Bhattacharya is Professor of Behavioural Medicine at the University of Leicester, UK. As a former primary care pharmacist, she has experience of both practice and research into […]
Missing crucial doses of medicines and vaccines could become a thing of the past thanks to Rice University bioengineers’ next-level technology for making time-released drugs. “This is a […]
Although the Inflation Reduction Act of 2022 (IRA) aimed to increase patient access to prescription drugs and decrease spending, researchers warn that it may have unintended negative impacts […]
A stop smoking mobile app that senses where and when you might be triggered to light up could help people quit – according to University of East Anglia […]
The European Medicines Agency (EMA) approved a total of 89 new medicines in 2022. Of these, 41 had a new active substance which had never been authorised in […]
European countries experienced significant shortages of medicines as seasonal illnesses spread across the continent. Now authorities at EU level are working to avoid a repeat of the problem, […]